Rubraca
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
NEW DRUG APPROVALS Rubraca for Ovarian Cancer The FDA has granted accelerated approval to rucaparib (Rubraca, Clovis Oncology) to…
The FDA granted accelerated approval to rucaparib (Rubraca), a PARP inhibitor, for the treatment of women with deleterious BRCA…